Table 1.
Long allele non-carriers | Long allele carriers | Totals | Incidence (%) | Statistics (P value) |
||
---|---|---|---|---|---|---|
Baseline group |
||||||
Healthy: no BC family hx n = 105 | Healthy: all n = 174 | |||||
Healthy volunteers | ||||||
No BC family hx | 100 | 5 | 105 | 4.8 | – | 0.799 |
BC family hx | 64 | 5 | 69 | 8.2 | 0.520 | 0.514 |
All healthy volunteers | 164 | 10 | 174 | 5.7 | 0.791 | – |
Cancer patients | ||||||
Breast cancer | 126 | 21 | 147 | 14.3* | 0.020 | 0.013 |
Other cancers | 192 | 15 | 207 | 7.3 | 0.471 | 0.791 |
Total | 482 | 46 | 528 | 8.7 | – | – |
Note: “BC family hx” refers to first degree (sister, daughter, or mother) or second degree (grandmother, aunt, niece, or granddaughter) family members with breast cancer. “Carriers” refer to persons in which the long allele (defined as at least 13 copies of the AAAG motif) is present. Asterisk indicates a statistically significant difference between the incidence of long allele carriers in breast cancer patients, compared to cancer-free volunteers, based on Fisher's exact test (P value = 0.0134, two-tailed comparison). A detailed list of patients and genotyping information is provided as Online Resource 1
BC breast cancer, hx history